← DSP Mutual Fund

DSP Healthcare Fund - Direct Plan - Growth

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
23
Jun 2026
Equity Holdings
₹2,671.89 Cr
Equity only, excl. debt & cash
Top 5 Weight
38.1%
Moderate
Top 10 Weight
56.9%
Moderate
Changes
22
1 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
60.4% of portfolio
📋 What Happened This Month DSP Healthcare Fund made 1 new addition and exited 1 stock this month. The biggest new buy was Syngene International Limited (Healthcare Services) at 1.38% weight. Laurus Labs Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 3.76%. Among existing holdings, Alkem Laboratories Limited saw the biggest increase — now at 2.61% of the portfolio. Emcure Pharmaceuticals Limited was trimmed the most, now at 0.37%. Cipla Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 60.4%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · DSP Healthcare Fund - Direct Plan - Growth

1M
+6.66%
3M
+17.90%
6M
+15.48%
1Y
+11.51%
Latest NAV
₹49.40
14 Jul 2026
52W High
₹49.58
-0% from High
52W Low
₹38.55
+28% from Low
Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025
-4.6%
2024
+42.6%
2023
+36.8%
2022
-6.5%
2021
+25.1%
2020
+80.0%
2019
+9.6%
Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg
28.5%
+ve in 80% windows
95.7% / -13.3%
3Y Rolling Avg
24.2% p.a.
+ve in 100% windows
36.0% / 14.2%
5Y Rolling Avg
26.2% p.a.
+ve in 100% windows
35.8% / 14.5%
Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff
-16.1%
Rec: Jun 2026 (1yr 8mo)
COVID-19 Crash
-21.7%
Rec: Apr 2020 (1 mo)
2022 Rate Hike
-17.9%
Rec: Jun 2023 (1yr 5mo)
2018 IL&FS
Pre-inception
Rec: N/A
Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)
1.72
Return per unit of risk. >1 is good.
Sortino Ratio (3Y)
2.52
Penalises downside volatility only.
Std Deviation (3Y)
12.7%
Lower = more consistent returns.
NAV Chart ₹49.40 14 Jul 2026
Simple Moving Avg: Click to draw · click again to remove
DSP Healthcare Fund - Direct Plan - Growth
Chart shows indexed performance (base = 100). Actual NAV: ₹49.40
Sector Shift Industry allocation month-over-month
Apr 2026 → May 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 65.1% 61.4% ▼ -3.6%
Healthcare Services 12.5% 12.7% ▲ +0.2%
Insurance 1.4% 1.3% ● 0.0%
Healthcare Equipment & Supplies 0.2% 0.2% ● +0.0%
Retailing 0.5% 0.0% ▼ -0.5%
May 2026 → Jun 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 61.4% 60.4% ▼ -1.0%
Healthcare Services 12.7% 14.3% ▲ +1.5%
Insurance 1.3% 1.2% ▼ -0.1%
Healthcare Equipment & Supplies 0.2% 0.2% ● 0.0%
🟢
Biggest New Buy
Syngene International Limited
1.38% weight · Healthcare Services
🔴
Biggest Exit
Laurus Labs Limited
3.76% was held · Pharmaceuticals & Biotechnology
↑
Biggest Add
Alkem Laboratories Limited
+1.99% · now 2.61%
↓
Biggest Trim
Emcure Pharmaceuticals Limited
-1.14% · now 0.37%
🤝 Other funds also bought this month
Syngene International Limited 4 funds
Syngene International Limited
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
IB52-Groww Nifty Smallcap 250 ETF
ICICI Prudential Nifty Smallcap 250 ETF + more
👋 Other funds also exited
Laurus Labs Limited 7 funds
Laurus Labs Limited
Navi Nifty Smallcap 250 Momentum quality index fund- Direct Plan
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan + more

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 → Jun 2026
🟢 1 New Entry 🔴 1 Exit ↑ 11 Increased ↓ 9 Decreased
#StockSectorWeight (Jun 2026)
1
Syngene International Limited
₹48.66 Cr
 Healthcare Services 1.38%
#StockSectorLast Weight (May 2026)
1
Laurus Labs Limited
₹124.51 Cr
 Pharmaceuticals & Biotechnology 3.76%
#StockSectorMay 2026Jun 2026Change
1
Alkem Laboratories Limited
₹91.79 Cr
 Pharmaceuticals & Biotechnology 0.62% 2.61% +1.99%
2
Cipla Limited
₹293.28 Cr
 Pharmaceuticals & Biotechnology 7.68% 8.35% +0.67%
3
Unichem Laboratories Ltd.
₹51.28 Cr
 Pharmaceuticals & Biotechnology 0.90% 1.46% +0.56%
4
IPCA Laboratories Limited
₹288.55 Cr
 Pharmaceuticals & Biotechnology 7.81% 8.21% +0.40%
5
Gland Pharma Limited
₹229.71 Cr
 Pharmaceuticals & Biotechnology 6.26% 6.54% +0.28%
6
Concord Biotech Limited
₹63.59 Cr
 Pharmaceuticals & Biotechnology 1.58% 1.81% +0.23%
7
Kovai Medical Center and Hospital Limited
₹100.78 Cr
 Healthcare Services 2.68% 2.87% +0.19%
8
Alembic Pharmaceuticals Limited
₹118.68 Cr
 Pharmaceuticals & Biotechnology 3.21% 3.38% +0.17%
9
Indoco Remedies Ltd
₹77.64 Cr
 Pharmaceuticals & Biotechnology 2.06% 2.21% +0.15%
10
Nephrocare Health Services Ltd
₹43.01 Cr
 Healthcare Services 1.15% 1.22% +0.07%
#StockSectorMay 2026Jun 2026Change
1
Emcure Pharmaceuticals Limited
₹12.85 Cr
 Pharmaceuticals & Biotechnology 1.51% 0.37% -1.14%
2
Pfizer Limited
₹89.07 Cr
 Pharmaceuticals & Biotechnology 2.79% 2.53% -0.26%
3
Sun Pharmaceutical Industries Limited
₹286.00 Cr
 Pharmaceuticals & Biotechnology 8.35% 8.14% -0.21%
4
ICICI Lombard General Insurance Company Limited
₹42.05 Cr
 Insurance 1.31% 1.20% -0.11%
5
Vijaya Diagnostic Centre Limited
₹126.54 Cr
 Healthcare Services 3.70% 3.60% -0.10%
6
Aarti Drugs Ltd
₹32.20 Cr
 Pharmaceuticals & Biotechnology 0.98% 0.92% -0.06%
7
Procter & Gamble Health Limited
₹100.77 Cr
 Pharmaceuticals & Biotechnology 2.92% 2.87% -0.05%
8
Cohance Lifesciences Limited
₹145.05 Cr
 Pharmaceuticals & Biotechnology 4.15% 4.13% -0.02%
9
EQ - LAXMI DENTAL LIMITED
₹6.31 Cr
 Healthcare Equipment & Supplies 0.20% 0.18% -0.02%

What Stocks Does This Fund Hold?

23 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
Cipla Limited
₹293.28 Cr
 Pharmaceuticals & Biotechnology
8.35%
2
IPCA Laboratories Limited
₹288.55 Cr
 Pharmaceuticals & Biotechnology
8.21%
3
Sun Pharmaceutical Industries Limited
₹286.00 Cr
 Pharmaceuticals & Biotechnology
8.14%
4
Sai Life Sciences Limited
₹241.60 Cr
 Pharmaceuticals & Biotechnology
6.88%
5
Gland Pharma Limited
₹229.71 Cr
 Pharmaceuticals & Biotechnology
6.54%
6
Apollo Hospitals Enterprise Limited
₹169.10 Cr
 Healthcare Services
4.81%
7
Cohance Lifesciences Limited
₹145.05 Cr
 Pharmaceuticals & Biotechnology
4.13%
8
Vijaya Diagnostic Centre Limited
₹126.54 Cr
 Healthcare Services
3.60%
9
Alembic Pharmaceuticals Limited
₹118.68 Cr
 Pharmaceuticals & Biotechnology
3.38%
10
Kovai Medical Center and Hospital Limited
₹100.78 Cr
 Healthcare Services
2.87%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 DSP Mutual Fund — Portfolio & Holdings
See all funds managed by DSP Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.